SEPTEMBER 2, 2019
- Catherine Pastor. Speaker presentation
- Bruno Hagenbuch. New insights into sinusoidal transporters
- Dietrich Keppler. Interactions canalicular/sinusoidal transporters
- Per Artursson. Hepatocyte subpopulations and proteomics
- Olivier Fardel. Hepatocyte transporters and environmental chemicals
- Shuiying Hu. OATP1B1 and tyrosine kinase
- Nicolas Tournier. Imaging and transporter function
- Catherine Pastor. Hepatocyte concentrations in IPRL
- Jash Unadkat. Predicting intracellular hepatic concentrations of drugs
- Steven Sourbron. EOB-DTPA kinetic modelling
- Kenneth Brouwer. Prediction of cholestatic hepatotoxicity
SEPTEMBER 3, 2019
- Catherine Pastor. Speaker presentation
- Francesco Negro. Viral hepatitis and transporters
- Raymond Evers. Hepatic transporters and renal impairment
- Kim Brouwer. Hepatic transporters and liver disease
- Catherine Pastor. EOB-DTPA and transporter scores
- Bernard van Beers. EOB-DTPA MRI and chronic liver disease
- Kim Frisch. Bile acid tracer and enterohepatic circulation by PET
- Susanne Keiding. PET with radiolabelled bile acid CSar
- Sharyn Baker. Sorafenib distribution in the liver
- Alex Sparreboom. OCT3 and doxorubicin cardiotoxicity
- Nathan Cherrington. Multiple mechanisms in NASH
- Oliver Langer. OATP2B1-mediated uptake of erlotinib and PET
SEPTEMBER 4, 2019
- Catherine Pastor. Speaker presentation
- Gerd Kullak-Ublick. Transporters and DILI
- Birk Poller. Kpuu and drug induced cholestasis risk
- Gerry Kenna. TRISTAN overview
- Irene Hernández Lozano. PET to quantify ABCB1 and ABCG2 activity
- Paul Hockings. Preclinical EOB-DTPA MRI and transporter inhibition
- Sirisha Tadimalla. Clinical EOB-DTPA MRI and transporter inhibition
- Jacqueline Benzençon. Coproporphyrin concentrations in PKD rats